Results 161 to 170 of about 12,666,103 (318)
"The antibiotic paradox" in allogeneic stem cell transplantation. [PDF]
Weber D +14 more
europepmc +1 more source
Moyamoya Disease and the Risk of Parkinson's Disease
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo +9 more
wiley +1 more source
Stem cell-specific NF-κB is required for stem cell survival and epithelial regeneration upon intestinal damage. [PDF]
Joly A, Ferguson M, Shin M, Foley E.
europepmc +1 more source
Induced pluripotent stem cell technology: a decade of progress
Yanhong Shi +3 more
semanticscholar +1 more source
The Diverse Neuromuscular Spectrum of VPS13A Disease
ABSTRACT Objective VPS13A disease (chorea‐acanthocytosis) is a rare neurodegenerative disorder caused by biallelic variants in VPS13A, typically presenting with hyperkinetic movement disorders, while neuromuscular signs are often mild. The aim of the project was to investigate the frequency and severity of neuromuscular impairment in VPS13A disease ...
Anne Buchberger +16 more
wiley +1 more source
Engineering hypoimmune stem cell-derived beta cells. [PDF]
Licht BJM, Duffy GP, Levey RE.
europepmc +1 more source
Identification of the haematopoietic stem cell niche and control of the niche size
Jiwang Zhang +13 more
semanticscholar +1 more source
ABSTRACT Objective The optimal treatment for neurosarcoidosis myelitis is uncertain. We characterize incident neurosarcoidosis myelitis and assess treatment response by MRI and clinical scales. Methods Incident probable or definite neurosarcoidosis myelitis in adults was retrospectively identified from 13 academic medical centers.
Giovanna S. Manzano +39 more
wiley +1 more source
Next generation targeted non-genotoxic conditioning for hematopoietic stem cell and hematopoietic stem cell-based gene therapy. [PDF]
Okalova J, Spencer TH, Chandrakasan S.
europepmc +1 more source

